Latest news
Avalo Therapeutics Announces Plans for Phase 3 Abdakibart HS Program, Advancement of AVTX-010 and Second Quarter 2026 Financial Results - Quiver QuantitativeQuiver Quantitative · Thu, 06 Aug 2026 11:15:00 GMTKyverna Therapeutics: 'Strong Buy' On ElevateBio Manufacturing Deal And RA Program Advancement - Seeking AlphaSeeking Alpha · Wed, 29 Jul 2026 19:14:53 GMT